Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on Modafinil for Improving Cognitive Deficits in Multiple Sclerosis Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Portugal
  • Study on the Effects of Ozanimod in Patients with Relapsing-Remitting Multiple Sclerosis

    Recruiting

    3 1 1
    Investigated Drugs:
    Italy
  • Study on the Effects of Annual vs. Semi-Annual Ocrelizumab Infusions in Patients with Active Multiple Sclerosis After 2 Years of Initial Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Comparison of ocrelizumab and rituximab treatment in adults with active relapsing-remitting multiple sclerosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Norway Sweden
  • Indapamide for Reducing Disability Progression in Adults with Primary and Secondary Progressive Multiple Sclerosis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Safety and Tolerability of Oral SUN-627 in Adults with Non‑Active Progressive Multiple Sclerosis (SPMS/PPMS) – Phase 2a Study

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Finland
  • Randomized Study of Tolebrutinib Versus Rituximab in Adults with Multiple Sclerosis

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    Sweden
  • Study of the safety and effectiveness of tolDC therapy in patients with progressive forms of multiple sclerosis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Spain
  • Effect of cladribine tablets on immune synapse in patients with relapsing multiple sclerosis

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    Greece
  • A study testing hydroxychloroquine to reduce brain inflammation in patients with progressive multiple sclerosis

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    Finland